ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
De-risking vaccine development: Insights spanning decades of experience
Anti-Gram-negative beta-lactams in jeopardy: The rise of PBP3 mutations
Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
Two new oral drugs for gonorrhea!
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
Lancet: 10-20-30 targets to address AMR by 2030
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
The 37,000-year view: Infections in Eurasia
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet









